| 000 | 01204 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516055720.0 | ||
| 264 | 0 | _c20120307 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1098-2396 | ||
| 024 | 7 |
_a10.1002/syn.20987 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeeman, Philip | |
| 245 | 0 | 0 |
_aDopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans. _h[electronic resource] |
| 260 |
_bSynapse (New York, N.Y.) _cJan 2012 |
||
| 300 |
_a88-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
| 650 | 0 | 4 | _aTritium |
| 773 | 0 |
_tSynapse (New York, N.Y.) _gvol. 66 _gno. 1 _gp. 88-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/syn.20987 _zAvailable from publisher's website |
| 999 |
_c21191123 _d21191123 |
||